# Section 195: Famotidine

---

Famotidine
206
Famotidine
Mechanism of Action
Competitively inhibits histamine at histamine H2-receptor site, thus decreasing gastric secretion while pepsin remains at a stable level.
Uses
Short-term treatment of active duodenal ulcer, maintenance therapy for duodenal ulcer, Zollinger-Ellison syndrome, multiple endocrine
adenomas, gastric ulcers; gastroesophageal reflux disease, heartburn
Unlabeled uses: GI disorders in those taking NSAIDs; urticaria; prevention of stress ulcers, aspiration pneumonitis, inactivation of oral
pancreatic enzymes in pancreatic disorders
Contraindications
Hypersensitivity
Precautions
Pregnancy (B), breastfeeding, children <12 years old, geriatric patients, severe renal/hepatic disease
Protocol Uses
Allergic Reaction – Adult (p46), Allergic Reaction – Peds (p100)
Side Effects
CNS: Headache, dizziness, paresthesia, depression, anxiety, somnolence, insomnia, fever, seizures in renal disease
CV: Dysrhythmias, QT prolongation in impaired renal function
EENT: Taste change, tinnitus, orbital edema
Skin: Rash, toxic epidermal necrolysis, Stevens-Johnson syndrome
MS: Myalgias, arthralgias
Resp: Pneumonia
Pharmacokinetics
Plasma protein binding 15-20%, metabolized in liver 30% (active metabolites), 70% excreted by kidneys, half life 2½-3½ hours;
IV – onset immediate, peak 30-60 minutes, duration 8-15 hours
Pregnancy Category – B
Interactions
Decrease: absorption – ketoconazole, itraconazole, cefpodoxime, cefditoren
Decrease: famotidine absorption – antacids
Decrease: effect of – atazanavir, delavirdine
EMT Considerations
Assess for signs of ulcers – epigastric pain, abdominal pain, frank or occult blood in emesis
Assess for signs of allergic reaction – redness, hives, itching
Treatment of Overdose
Discontinue product; supportive care
Pharmaceuticals
~ This Space Intentionally Left Blank ~
B EMT
A A-EMT
P Paramedic
M Medical Control
EMR
